Urological cancer, Malmö
81 – 90 of 553
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis
- Contribution to journal › Article
-
Mark
P90 ribosomal S6 kinases : A bona fide target for novel targeted anticancer therapies?
- Contribution to journal › Scientific review
-
Mark
Systematic Augmentation in HSV Space for Semantic Segmentation of Prostate Biopsies
(2023) 22nd Scandinavian Conference on Image Analysis, SCIA 2023 In Lecture Notes in Computer Science 13886. p.293-308
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Men's Perception of Being Invited for Prostate Cancer Testing and the Information About Its Pros and Cons—A Survey from Two Population-based Testing Programmes
- Contribution to journal › Article
-
Mark
Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer
- Contribution to journal › Article
-
Mark
Pancreatic Cancer Organoids : An Emerging Platform for Precision Medicine?
- Contribution to journal › Scientific review
-
Mark
Automated quantification of PET/CT skeletal tumor burden in prostate cancer using artificial intelligence : The PET index
- Contribution to journal › Article
-
Mark
Incidence and associated risk factors of venous thromboembolism after open and laparoscopic partial nephrectomy in patients administered short-period thromboprophylaxis : a Danish nationwide population-based cohort study
- Contribution to journal › Article
-
Mark
Correlation between ADC, ADC ratio, and Gleason Grade group in prostate cancer patients undergoing radical prostatectomy : Retrospective multicenter study with different MRI scanners
- Contribution to journal › Article
-
Mark
The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma
- Contribution to journal › Article
